Brackenridge S, John N, Fruh K, Borrow P, McMichael A
Front Immunol. 2024; 15:1329032.
PMID: 38571959
PMC: 10987726.
DOI: 10.3389/fimmu.2024.1329032.
Hilton H, Parham P
Tissue Antigens. 2013; 81(4):212-20.
PMID: 23510417
PMC: 3615166.
DOI: 10.1111/tan.12095.
Jing L, Haas J, Chong T, Bruckner J, Dann G, Dong L
J Clin Invest. 2012; 122(2):654-73.
PMID: 22214845
PMC: 3266794.
DOI: 10.1172/JCI60556.
Sergeeva A, Alatrash G, He H, Ruisaard K, Lu S, Wygant J
Blood. 2011; 117(16):4262-72.
PMID: 21296998
PMC: 3087478.
DOI: 10.1182/blood-2010-07-299248.
Wolfel C, Lennerz V, Lindemann E, Hess G, Derigs H, Huber C
Cancer Immunol Immunother. 2007; 57(6):849-57.
PMID: 18004563
PMC: 11030130.
DOI: 10.1007/s00262-007-0421-1.
Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.
Alexander M, Bor Y, Ravichandran K, Hammarskjold M, Rekosh D
J Virol. 2004; 78(4):1685-96.
PMID: 14747534
PMC: 369412.
DOI: 10.1128/jvi.78.4.1685-1696.2004.
In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.
Sun Y, Moller P, Berking C, Schlupen E, Volkenandt M, Schadendorf D
Immunology. 1999; 98(4):535-40.
PMID: 10594685
PMC: 2326956.
DOI: 10.1046/j.1365-2567.1999.00902.x.
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.
Wang Z, Marincola F, Rivoltini L, Parmiani G, Ferrone S
J Exp Med. 1999; 190(2):205-15.
PMID: 10432284
PMC: 2195569.
DOI: 10.1084/jem.190.2.205.
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.
He X, Rehermann B, Lopez-Labrador F, Boisvert J, Cheung R, Mumm J
Proc Natl Acad Sci U S A. 1999; 96(10):5692-7.
PMID: 10318946
PMC: 21922.
DOI: 10.1073/pnas.96.10.5692.
Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion.
Koo D, Welsh K, Roake J, Morris P, Fuggle S
Am J Pathol. 1998; 153(2):557-66.
PMID: 9708815
PMC: 1852972.
DOI: 10.1016/S0002-9440(10)65598-8.
Calreticulin associates with non-HLA-A,-B class I proteins in the human choriocarcinoma cell lines JEG-3 and BeWo.
WAINWRIGHT S, Simpson K, Holmes C
Immunology. 1998; 93(3):437-45.
PMID: 9640257
PMC: 1364095.
DOI: 10.1046/j.1365-2567.1998.00439.x.
A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
Brandle D, Brasseur F, Weynants P, Boon T, Van den Eynde B
J Exp Med. 1996; 183(6):2501-8.
PMID: 8676070
PMC: 2192619.
DOI: 10.1084/jem.183.6.2501.
Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C.
Deryckere F, Burgert H
J Virol. 1996; 70(5):2832-41.
PMID: 8627757
PMC: 190140.
DOI: 10.1128/JVI.70.5.2832-2841.1996.
Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P, Kaklamanis L, Pezzella F, Harris A, Gatter K
Br J Cancer. 1996; 73(2):148-53.
PMID: 8546899
PMC: 2074307.
DOI: 10.1038/bjc.1996.28.
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P
J Exp Med. 1993; 177(4):989-98.
PMID: 8459226
PMC: 2190978.
DOI: 10.1084/jem.177.4.989.
Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.
Koelle D, Tigges M, Burke R, Symington F, Riddell S, Abbo H
J Clin Invest. 1993; 91(3):961-8.
PMID: 8383706
PMC: 288048.
DOI: 10.1172/JCI116317.
Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
Litwin V, Gumperz J, Parham P, Phillips J, Lanier L
J Exp Med. 1993; 178(4):1321-36.
PMID: 8376937
PMC: 2191205.
DOI: 10.1084/jem.178.4.1321.
Restoration of CTL recognition of a mutant FMP peptide by a compensatory change in HLA-A2.
Matsui M, Frelinger J
Immunogenetics. 1994; 40(1):66-9.
PMID: 8206528
DOI: 10.1007/BF00163966.
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.
Castelli C, Storkus W, Maeurer M, Martin D, Huang E, Pramanik B
J Exp Med. 1995; 181(1):363-8.
PMID: 7807017
PMC: 2191826.
DOI: 10.1084/jem.181.1.363.
Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Colbert R, Rowland-Jones S, McMichael A, Frelinger J
Proc Natl Acad Sci U S A. 1993; 90(14):6879-83.
PMID: 7688130
PMC: 47036.
DOI: 10.1073/pnas.90.14.6879.